Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00641108 · ClinicalTrials.gov registry record · Phase 2
Effects of Cognitive Behavioral Therapy on Brain Serotonin Activity in People With Depression
A Phase 2 study, sponsored by University of Pennsylvania.
- Completed
- Registry status
- Phase 2
- Development phase
- 30
- Enrollment target
NCT00641108: Completed Phase 2 study, sponsored by University of Pennsylvania.
NCT00641108 is a Phase 2 study that has completed, run by University of Pennsylvania. The registered enrollment target is 30 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00641108, a Phase 2 study, has completed, sponsored by University of Pennsylvania.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 30 participants
- Enrollment target
Study Summary
This study will examine changes in brain serotonin activity in people with depression before and after they receive cognitive behavioral therapy.
Interventions
- DRUG ADAM SPECT plus Cognitive Therapy
- DRUG ADAM SPECT plus No Therapy
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 30 participants |
| Start Date | 2008-01 |
| Est. Completion | 2011-12 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00641108
The ClinicalTrials.gov registry entry for NCT00641108 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 30 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Pennsylvania, which has 1,423 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which ADAM SPECT plus Cognitive Therapy is the first listed.
NCT00641108 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00641108 about?
NCT00641108 is a clinical study titled "Effects of Cognitive Behavioral Therapy on Brain Serotonin Activity in People With Depression". This study will examine changes in brain serotonin activity in people with depression before and after they receive cognitive behavioral therapy.
What is the current status of trial NCT00641108?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 30 participants. The study started on 2008-01. Estimated completion is 2011-12.
What interventions are being tested in trial NCT00641108?
The interventions under investigation include: ADAM SPECT plus Cognitive Therapy (DRUG), ADAM SPECT plus No Therapy (DRUG).
Who is sponsoring clinical trial NCT00641108?
This trial is sponsored by University of Pennsylvania, which has 1,423 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.